Lingye Pharmaceutical

Hangzhou Lingye Pharmaceutical Technology Co., Ltd. was founded by Dr. Sheng Xiaoxia. Since its establishment, Lingye Pharmaceutical has continuously provided high-quality R&D technical services to the pharmaceutical industry, focusing on new drug polymorph research and generic drug consistency evaluation, and has become a benchmark enterprise in the field of drug polymorph research. Over the past five years, the company has simultaneously laid out complex formulation development and innovative drug development and introduction. The company owns nearly 100 invention patents in China and the United States. It has laid out in fields such as immunity, anti-infection, respiratory and blood, with dozens of products under research. From a purely CRO technical service enterprise in its early days, Lingye Pharmaceutical has gradually developed into a comprehensive pharmaceutical enterprise with a substantial product pipeline that effectively integrates upstream and downstream advantageous resources to achieve drug development, production, introduction and sales as one.
 Company Model & Innovation
R&D as the core, quality as the foundation, with an international perspective, positioning in the Chinese and US markets, and dual-channel product applications in China and the US. Driven by R&D, from API development, complex formulation development, drug registration and approval to production and global sales, it achieves full industry chain connectivity through upstream and downstream resource integration.
1. Technological innovation: By designing and controlling the microstructure of drugs, achieve precise drug release and improve clinical efficacy and patient compliance;
2. Product innovation: Leveraging technical advantages in drug microstructure control, focus on the fields of immunity, anti-infection and allergy, develop poorly soluble solid oral formulations, topical semi-solid formulations and complex injections, and provide comprehensive solutions for multi-symptom management for patients;
3. Collaborative innovation: Through independent development, collaborative development and technology introduction, with Lingye's strengths, establish long-term mutual trust and mutual benefit cooperation with partners, and bring developmentally challenging drugs to the global market.
 Company Environment
The company is located by the beautiful Qiantang River, with convenient subway and transportation nearby. The working environment is comfortable, clean and generous. It has a 3,000 m2 R&D innovation center, a 1,000 m2 pilot workshop and an 8,000 m2 multi-functional drug production base.
 Honor Wall
National High-tech Enterprise, Zhejiang Provincial R&D Center for Highly Variable Drugs, undertaking the major special project of highly variable drug development in Hangzhou; core unit of the Chemical Pharmaceutical Formulation Product Technology Innovation Strategic Alliance of Zhejiang Provincial Department of Science and Technology; CNAS accreditation qualification of the China National Accreditation Service for Conformity Assessment, and has passed on-site inspections of R&D by the National Medical Products Administration for many times; in 2018, it passed the US FDA GMP on-site inspection with zero defects, becoming one of the R&D innovation centers that have passed US FDA inspection.
 Main Business
1. Drug polymorph research: polymorph screening and druggability evaluation, polymorph control in APIs and formulations, qualitative and quantitative analysis of polymorph impurities and crystalline residues;
2. Complex formulation development: complex oral formulations; sustained and controlled release formulations, enteric-coated formulations, osmotic pump formulations, gastroretentive formulations, etc.; complex injections: liposomes, microspheres, injectable gels, microemulsions, nanoemulsions, etc.; complex topical formulations, patches
3. Pharmaceutical formulation production: meeting registration batch, clinical sample supply and commercial production; semi-solid, solution, solid oral and injection, etc.; meeting the GMP requirements of the US FDA and China NMPA.
 Hi Work & Hi Life
Here, there is a young team with an average age of 29, 92% holding a bachelor's degree or above, including 8% with doctoral degrees and 30% with master's degrees. You cannot imagine what our team is like when working? Full of drive and vitality, young and inexperienced but remarkably gifted, deeply in love with the R&D industry, often arguing red-faced over how to develop analytical methods and how to set process parameters; in spare time, sharing learning videos, courseware, etc. to learn and improve together; the company provides attractive training courses, whatever you want to learn is available; a pleasant, harmonious and融洽 working atmosphere, coupled with colorful employee activities such as extracurricular development, dinners, KTV, etc., enables you to achieve a consistent balance between work and life.
This is Lingye, a young pharmaceutical company. As long as you are excellent enough, this is your stage.
 Founder Profile of Lingye
Dr. Sheng Xiaoxia is an expert of the Innovation and Entrepreneurship Talent Program of the Ministry of Science and Technology, a professor-level senior engineer, chairperson of the Polymorphic Drug Branch of the Chinese Crystal Association, a member of the Chemical Drugs and Antibiotics Professional Committee of the Zhejiang Pharmaceutical Association, a member of the Smart Pharmacy Professional Committee of the Zhejiang Digital Pharmacology Society, and a part-time researcher at Zhejiang University and Zhejiang University of Technology. Bachelor's degree in Chemistry from Peking University, Ph.D. in Chemical Engineering from the University of Minnesota, USA, postdoctoral research at the Massachusetts Institute of Technology on the development of antibacterial polymer surface materials, has published multiple academic papers in internationally renowned academic journals such as PNAS, J Am Soc Nephrol, J Am Chem Soc, two of which were selected as journal covers and one was specially reported by Nature; applied for more than 80 invention patents, with more than 50 invention patents authorized; was employed by AbbVie, engaged in new drug development, leading senior R&D personnel from synthesis, materials, process and formulation departments to specialize in the control and optimization of drugs with poor solid-state properties in clinical phases I to III.
 Competitive Compensation and Benefits System
1. Competitive salary, reasonable performance incentive mechanism (salary, project award/performance award, year-end bonus);
2. Sound and generous benefits (medical insurance, pension insurance, unemployment insurance, work-related injury insurance, maternity insurance and housing provident fund);
3. Good company benefits (housing subsidy, meal allowance, transportation subsidy, seniority allowance, post allowance, duty allowance, high-temperature allowance, etc.);
4. Humanistic care (annual welfare medical examination, irregular team building, snacks and tea, holiday benefits, birthday benefits, etc.);
5. Enjoy various holidays: paid annual leave, two-day weekend, statutory holidays, company-specific welfare leave, marriage leave, maternity leave, bereavement leave and paternity leave for male employees, etc.
Sincerely welcome people with lofty ideals to join the Lingye family and build the future together!